Your institution may have access to this item. Find your institution then sign in to continue.
Title
Can open-source R&D reinvigorate drug research?
Authors
Munos, Bernard
Abstract
The low number of novel therapeutics approved by the US FDA in recent years continues to cause great concern about productivity and declining innovation. Can open-source drug research and development, using principles pioneered by the highly successful open-source software movement, help revive the industry?
Publication
Nature reviews. Drug discovery, 2006, Vol 5, Issue 9, p723